Related Experiment Video
Updated: Oct 27, 2025

Author Spotlight: Exploring Huotan Jiedu Tongluo Decoction as an Antihypertensive Drug
Published on: May 17, 2024
Association of Hypertension with Severity and Mortality in Hospitalized Patients with COVID-19 in Wuhan, China: A
You-Ping Deng1, Wen Xie2, Tao Liu3
1Department of Pediatrics, Zhongnan Hospital of Wuhan University, Wuhan - China.
Insights
Hypertension is linked to increased severity and mortality in hospitalized COVID-19 patients. Early, aggressive treatment for these patients, particularly for cardiac and kidney issues, is recommended.
Area of Science:
- Cardiology
- Infectious Diseases
- Public Health
Background:
- Coronavirus disease 2019 (COVID-19), caused by SARS-CoV-2, has led to a global pandemic.
- Understanding comorbidities associated with severe COVID-19 outcomes is crucial for patient management.
- Hypertension is a prevalent comorbidity with potential implications for COVID-19 prognosis.
Purpose of the Study:
- To investigate the association between hypertension and the severity and mortality of COVID-19 in hospitalized patients.
- To identify clinical characteristics and outcomes of COVID-19 patients with and without hypertension.
Main Methods:
- Retrospective, single-center case study involving 337 hospitalized COVID-19 patients.
- Data collected from January 20 to February 25, 2020, at the Seventh Hospital of Wuhan City.
- Statistical analysis performed with a significance level of 0.05.
Main Results:
- Of 337 patients, 112 (33.2%) had hypertension. Hypertensive patients were older and predominantly male.
- Hypertension was significantly associated with increased severity (severe/critical cases) and higher mortality rates (17.9% vs. 8.9%).
- Hypertensive patients exhibited more abnormal laboratory findings, including lymphopenia, inflammation, and impaired cardiac, liver, kidney, and lung function.
Conclusions:
- Hypertension is a significant risk factor for severe COVID-19 outcomes and mortality.
- COVID-19 patients with hypertension require vigilant monitoring for cardiac and kidney complications.
- Aggressive treatment strategies should be considered for hypertensive COVID-19 patients to mitigate adverse outcomes.
Background:
Coronavirus disease 2019 (COVID-19), caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has spread worldwide.
Objective:
To investigate the association between hypertension and severity/mortality in hospitalized patients with COVID-19 in Wuhan, China.
Methods:
A total of 337 patients diagnosed with COVID-19 at the Seventh Hospital of Wuhan City, from January 20 to February 25, 2020, were enrolled and analyzed in a retrospective, single-center case study. The significance level adopted in the statistical analysis was 0.05.
Results:
Of the 337 patients with confirmed diagnosis of COVID-19, 297 (87.8%) were discharged from the hospital and 40 patients (22.9%) died. The median age was 58 years (range, 18-91 years). There were 112 (33.2%) patients diagnosed with hypertension at admission (median age, 65.0 years [range, 38-91 years]; 67 [59.8%, 95%CI: 50.6%-69.0%] men, p=0.0209). Patients with hypertension presented a significantly higher portion of severe cases (69 [61.6%, 95%CI:52.5%-70.8%] vs. 117 [52.0%, 95%CI: 45.4%-58.6%] in severe patients and 23 [19.3%, 95%CI:12.9%-28.1%] vs. 27 [12.0%, 95%CI: 7.7%-16.3%] in critical patients, p=0.0014) and higher mortality rates (20 [17.9%, 95%CI: 10.7%-25.1%] vs. 20 [8.9%, 95%CI: 5.1%-12.6%, p=0.0202). Moreover, hypertensive patients presented abnormal levels of multiple indicators, such as lymphopenia, inflammation, heart, liver, kidney, and lung function at admission. The hypertension group still displayed higher levels of TnT and creatinine at approaching discharge.
Conclusion:
Hypertension is strongly associated with severity or mortality of COVID-19. Aggressive treatment may be considered for COVID-19 patients with hypertension, especially regarding cardiac and kidney injury.
Related Concept Videos
Hypertension III: Clinical Manifestations and Diagnostic Studies
Hypertension II: Pathophysiology
Hypertension I: Introduction
Hypertension and Regulation of Blood Pressure
Coronary Artery Disease III: Clinical Manifestations
Measurement of Blood Pressure
